Triglimimark-2 mg Tablet

Triglimimark-2 mg Tablet contains Glimepiride 2 mg. Prescription required.

Type 2 diabetes mellitus (non-insulin-dependent) to help control blood glucose along with diet and exercise; may be used alone or with other antidiabetic medicines as prescribed.

Glimepiride is a sulfonylurea that stimulates pancreatic beta cells to release insulin by closing ATP-sensitive potassium channels. This increases insulin secretion and helps lower blood glucose, especially after meals.

Take by mouth exactly as prescribed, usually once daily with breakfast or the first main meal. Swallow tablet with water; do not skip meals after taking it. Dose is individualized based on blood sugar; monitor glucose regularly.

Hypoglycaemia (low blood sugar), dizziness, headache, nausea, abdominal discomfort, diarrhoea, weight gain, skin rash

Risk of hypoglycaemia increases with missed meals, strenuous exercise, alcohol intake, or overdose. Use with caution in elderly, malnourished, liver or kidney impairment, and in patients with adrenal/pituitary insufficiency. Not for type 1 diabetes or diabetic ketoacidosis. Inform doctor if you have sulfonamide allergy; monitor for signs of low sugar (sweating, tremor, confusion).

Alcohol, insulin and other antidiabetics (increased hypoglycaemia), beta-blockers (mask hypoglycaemia symptoms), fluconazole/miconazole (may increase effect), rifampicin (may reduce effect), corticosteroids and thiazide diuretics (may raise glucose), warfarin (may alter anticoagulant effect), NSAIDs/salicylates (may increase hypoglycaemia)

Store below 25°C in a cool, dry place. Protect from light and moisture. Keep out of reach of children.

Amaryl 2 Tablet, Glimy 2 Tablet, Glimepiride 2 mg Tablet (generic), Zoryl 2 Tablet, Gemer 2 Tablet